These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 8334760)
1. Role of the kidney in the expression of low molecular weight factors with growth factor activity. Jacob C; Maachi F; el Farricha O; Dousset B; Kessler M; Belleville F; Nabet P Clin Nephrol; 1993 Jun; 39(6):327-34. PubMed ID: 8334760 [TBL] [Abstract][Full Text] [Related]
2. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
3. Effect of chronic renal failure and prednisolone on the growth hormone-insulin-like growth factor axis. Kapila P; Jones J; Rees L Pediatr Nephrol; 2001 Dec; 16(12):1099-104. PubMed ID: 11793109 [TBL] [Abstract][Full Text] [Related]
4. Role of the kidney in the production of a low molecular weight growth factor (MW < 1000 Da): experimental study in the pig. Jacob C; Hubert J; Maachi F; Punga-Maole A; Dousset B; Junke E; Belleville F Ren Fail; 1995 Jul; 17(4):339-47. PubMed ID: 7569107 [TBL] [Abstract][Full Text] [Related]
5. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696 [TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor-I and binding proteins (IGF BP-1 and IGF BP-3) concentrations after renal transplantation in adults. Hussenet F; Dousset B; Gervais P; Capiaumont J; Schuhmacher A; Nabet P; Kessler M Transplant Proc; 1996 Dec; 28(6):3615-20. PubMed ID: 8962397 [No Abstract] [Full Text] [Related]
7. Impact of graft failure on patient survival on dialysis: a comparison of transplant-naive and post-graft failure mortality rates. Rao PS; Schaubel DE; Saran R Nephrol Dial Transplant; 2005 Feb; 20(2):387-91. PubMed ID: 15585512 [TBL] [Abstract][Full Text] [Related]
8. Derangements of the somatotropic hormone axis in chronic renal failure. Tönshoff B; Blum WF; Mehls O Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352 [TBL] [Abstract][Full Text] [Related]
10. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of pretransplant serum cytokine levels in renal transplant recipients. Berber I; Yiğit B; Işitmangil G; Tellioğlu G; Ozgezer T; Gülle S; Türkmen F; Titiz I Transplant Proc; 2008; 40(1):92-3. PubMed ID: 18261555 [TBL] [Abstract][Full Text] [Related]
16. [Growth and renal function]. Antoniazzi F; Mengarda F; Lauriola S; Serra A; Zamboni G; Tatò L Pediatr Med Chir; 1997; 19(5):341-7. PubMed ID: 9493225 [TBL] [Abstract][Full Text] [Related]
17. A seric low molecular weight factor modulates IGFs effects on chick cartilage metabolism. Maachi F; Straczek J; Jacob C; Belleville F; Nabet P Life Sci; 1995; 56(25):2273-84. PubMed ID: 7791514 [TBL] [Abstract][Full Text] [Related]
18. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540 [TBL] [Abstract][Full Text] [Related]
19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808 [TBL] [Abstract][Full Text] [Related]
20. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation. Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]